TAbS







Following are the main features of YAbS database:
(1) The database encompasses therapeutic antibodies that are approved, currently in clinical trials, or were terminated during clinical studies that started after January 1, 2000.
(2) The database offers detailed information on therapeutic antibodies, covering antibody type, target antigen, primary and partner developer (companies), clinical trial dates for phases 1, 2, and 3, approving regulatory agency, therapeutic application, and a concise summary of each antibody or its developer company.
(3) The website provides a comprehensive set of search and filter tools.
(4) The database is updated bimonthly from data that is collected daily.



About The Antibody Society:

The Antibody Society, Inc. is an international non-profit trade association representing individuals and organizations involved in antibody research and development. The Society is an authoritative source of information about antibody therapeutics development, which is disseminated via our website, presentations and publications. In addition, the Society organizes conferences and webinars on antibody research and development and related topics. The Society also serves as the home for the Adaptive Immune Receptor Repertoire Community, which focuses on developing standards and protocols for curating, analyzing and sharing antibody B and T cell receptors. As a business association, the Society can engage with government and international agencies such as the World Health Organization to discuss topics that are important to the antibody community, such as international naming conventions. The Antibody Society is a 501(c)(6) non-profit organization, as designated by the US Internal Revenue Service. As such, donations of any kind, including corporate and standard membership fees, are not tax deductible.
Read privacy policy of The Antibody Society here